LONG-TERM INCENTIVE PLAN AWARDS (Tables)

6 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of stock options

					Weighted-
					Average
			Weighted-		Remaining
			Average		Contractual		Aggregate
			Exercise		Life		Intrinsic
Options	Shares		Price		(In Years)		Value
Outstanding as of June 30, 2025		392,001	$	4.64		0.58	$	117,600
Granted		–		–		–		–
Exercised		–		–		–		–
Cancelled		–		–		–		–
Forfeited or expired (1)		(245,001)		5.40		–		–
Outstanding as of December 31, 2025		147,000	$	3.38		0.99	$	145,530
Exercisable as of December 31, 2025		147,000	$	3.38		0.99	$	145,530

(1) A total of 245,001 shares of fully vested stock options, which had been previously granted through its 2020 employee stock option plan, lapsed and expired in July 2025.

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based upon our closing stock price of $4.37 as of December 31, 2025, which would have been received by the option holders had all option holders exercised their options as of that date. The weighted-average grant-date fair value of stock options outstanding as of December 31, 2025, in the amount of 147,000 shares was $2.83 per share. As of December 31, 2025, there was no unrecognized compensation cost related to non-vested stock options granted. 

A summary of the status of our stock options is presented below as of December 31, 2024:

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
				Exercise		Life		Intrinsic
Options	Shares			Price		(In Years)		Value
Outstanding as of June 30, 2024		627,001		$	4.24		2.88	$	130,200
Granted		–			–		–		–
Exercised		–			–		–		–
Cancelled		–			–		–		–
Forfeited or expired		(20,000	)		4.90		–		–
Outstanding as of December 31, 2024		607,001		$	4.20		1.40	$	550,240
Exercisable as of December 31, 2024		607,001		$	4.20		1.40	$	550,240